Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

144-83-2

Sulfapyridine

144-83-2
38710-26-8

Seneciphylline N-oxide

38710-26-8
72755-25-0

Senecivernine

72755-25-0
18559-94-9

Salbutamol

18559-94-9
2318-18-5

Senkirkine

2318-18-5
24916-50-5

Spiramycin I

24916-50-5
3810-74-0

Streptomycin sesquisulfate

3810-74-0
114438-33-4

Sulfamethoxazole hydroxylamine

114438-33-4
63-74-1

Sulfanilamide

63-74-1
946578-00-3

Sulfoxaflor

946578-00-3
91296-87-6

Sarafloxacin HCl

91296-87-6
79559-97-0

Sertraline HCl

79559-97-0
1220-83-3

Sulfamonomethoxin

1220-83-3
10418-03-8

Stanozolol

10418-03-8
654671-78-0

Sitagliptin Phosphate

654671-78-0
52-01-7

Spironolacton

52-01-7
2447-57-6

Sulfadoxine

2447-57-6
7081-44-9

Cloxacillin Sodium Salt Monohydrate

7081-44-9
64058-48-6

Spectinomycin sulfate hydrate

64058-48-6
80-35-3

Sulfamethoxypyridazine

80-35-3